Standout Papers
Citation Impact
Citing Papers
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Non-steroidal anti-inflammatory drugs for low back pain
2008
Physical fitness training for stroke patients
2020
Nonsteroidal Anti-Inflammatory Drugs for Low Back Pain
2008
Patient-centered integrated healthcare improves quality of life in Parkinson’s disease patients: a randomized controlled trial
2018
Parkinson's disease
2021 Standout
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Vascular dementia
2015 Standout
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer’s Disease Trials: An AIBL Study
2015 StandoutNobel
Non-specific low back pain
2016 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
2016
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug‐refractory epilepsy
2010
Therapeutics of Alzheimer's disease: Past, present and future
2013
Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbo-sciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study
2009
A review on Alzheimer's disease pathophysiology and its management: an update
2014
Diabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes
2014
Small vessel disease: mechanisms and clinical implications
2019 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Non-specific low back pain
2011 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Whither pathogenetic treatments for diabetic polyneuropathy?
2013
Lecanemab in Early Alzheimer’s Disease
2022 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
2014
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
Cerebrolysin for vascular dementia
2013
Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
2018
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Pharmacological Treatment and Prevention of Cerebral Small Vessel Disease: A Review of Potential Interventions
2015
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Acute back pain: benefits and risks of current treatments
2009
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
The ADAS‐Cog revisited: Novel composite scales based on ADAS‐Cog to improve efficiency in MCI and early AD trials
2012
Works of Alla Guekht being referenced
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin)
2017
Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
2010
Action Plan for Stroke in Europe 2018–2030
2018 Standout
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design
2013
Analgesic Efficacy and Safety of??Lornoxicam Quick-Release Formulation Compared with Diclofenac Potassium
2006
Factors influencing on quality of life in people with epilepsy
2006
Cerebrolysin improves symptoms and delays progression in patiens with Alzehimer's disease and vascular dementia
2012
Costs of illness and care in Parkinson's Disease: An evaluation in six countries
2010
Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action
2012
Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis
2022
Post‐stroke cognitive decline: an update and perspectives for clinical research
2014